These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 7836491

  • 1. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L.
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S, de Sonneville L, Licht R, Sergeant J, van Spronsen F.
    Dev Neuropsychol; 2002 Oct; 22(2):481-99. PubMed ID: 12537335
    [Abstract] [Full Text] [Related]

  • 3. Sustained attention in untreated non-PKU-hyperphenylalaninemia.
    Weglage J, Schmidt E, Fünders B, Pietsch M, Ullrich K.
    J Clin Exp Neuropsychol; 1996 Jun; 18(3):343-8. PubMed ID: 8877619
    [Abstract] [Full Text] [Related]

  • 4. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A, Prevor MB, Callender G, Druin DP.
    Monogr Soc Res Child Dev; 1997 Jun; 62(4):i-v, 1-208. PubMed ID: 9421921
    [Abstract] [Full Text] [Related]

  • 5. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J, Fromm J, van Teeffelen-Heithoff A, Möller HE, Koletzko B, Marquardt T, Rutsch F, Feldmann R.
    Mol Genet Metab; 2013 Jun; 110 Suppl():S44-8. PubMed ID: 24071437
    [Abstract] [Full Text] [Related]

  • 6. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K, Packman W, Sporri L, Needham M, Morgan C, Weisiger K, Packman S.
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [Abstract] [Full Text] [Related]

  • 7. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.
    Schmidt E, Burgard P, Rupp A.
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S82-6. PubMed ID: 8828617
    [Abstract] [Full Text] [Related]

  • 8. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J, Ullrich K, Pietsch M, Fünders B, Güttler F, Harms E.
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [Abstract] [Full Text] [Related]

  • 9. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.
    Clarke JT, Gates RD, Hogan SE, Barrett M, MacDonald GW.
    Am J Ment Retard; 1987 Nov; 92(3):255-62. PubMed ID: 3426836
    [Abstract] [Full Text] [Related]

  • 10. Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
    Martynyuk AE, Ucar DA, Yang DD, Norman WM, Carney PR, Dennis DM, Laipis PJ.
    Epilepsia; 2007 Jun; 48(6):1143-50. PubMed ID: 17484755
    [Abstract] [Full Text] [Related]

  • 11. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C, Kiener C, Meier N, Schmid P, Rauh M, Rascher W, Knerr I.
    Ann Nutr Metab; 2008 Jun; 53(2):91-5. PubMed ID: 18946205
    [Abstract] [Full Text] [Related]

  • 12. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM, Huijbregts SC, van Spronsen FJ, Verkerk PH, Sergeant JA, Licht R.
    Mol Genet Metab; 2010 Jun; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [Abstract] [Full Text] [Related]

  • 13. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V, Kurzius L, Forbes P, Waisbren S.
    Mol Genet Metab; 2008 Jun; 95(1-2):17-20. PubMed ID: 18703366
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study.
    Burgard P, Rey F, Rupp A, Abadie V, Rey J.
    Pediatr Res; 1997 Mar; 41(3):368-74. PubMed ID: 9078537
    [Abstract] [Full Text] [Related]

  • 15. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S, Ghosh-Jerath S, Thompson S, Rocca A, Joy P, Kemp A, Rae C, Green K, Wilcken B, Christodoulou J.
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [Abstract] [Full Text] [Related]

  • 16. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations.
    Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA.
    Neuropsychologia; 2002 May; 40(1):7-15. PubMed ID: 11595258
    [Abstract] [Full Text] [Related]

  • 17. A neuropsychological profile of off-diet adults with phenylketonuria.
    Moyle JJ, Fox AM, Bynevelt M, Arthur M, Burnett JR.
    J Clin Exp Neuropsychol; 2007 May; 29(4):436-41. PubMed ID: 17497567
    [Abstract] [Full Text] [Related]

  • 18. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F, Azen C, Guldberg P, Romstad A, Hanley WB, Levy HL, Matalon R, Rouse BM, Trefz F, de la Cruz F, Koch R.
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [Abstract] [Full Text] [Related]

  • 19. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, Bosch AM, Hollak CE, Rubio-Gozalbo ME, Brouwers MC, Hofstede FC, de Vries MC, Janssen MC, van der Ploeg AT, Langendonk JG, van Spronsen FJ.
    Mol Genet Metab; 2013 Dec; 110 Suppl():S57-61. PubMed ID: 24183792
    [Abstract] [Full Text] [Related]

  • 20. [The IQ of heterozygotes for phenylketonuria (PKU). indication of a blood phenylalanine-independent action of the PKU mutant (author's transl)].
    Thalhammer O, Havelec L, Knoll E, Wehle E.
    Wien Klin Wochenschr; 1977 Oct 28; 89(20):684-6. PubMed ID: 930099
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.